Antibiotics

Multinational Companies Continue To Produce Unregulated Antibiotics In India

Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle...
tuberculosis

Health Organisations Write to Narendra Modi, Seek Compulsory Licences For Tuberculosis Drugs

Six health organisations and survivors of drug-resistant tuberculosis, health organisations and the TB community have appealed to Prime Minister Narendra Modi to allow issuance...
IHC Annual Lecture

IHC Annual Lecture by Kiran Mazumdar-Shaw Delivered to a Packed Audience

Kiran Mazumdar-Shaw, CMD Biocon Limited and Chairperson, Association of Biotechnology Led Enterprises, delivered the IHC Annual Lecture 2018. A widely anticipated annual event in...
Amazon

Amazon Is Shaking Up A Healthcare Industry That’s Ripe For Disruption

The impact of a plan by Amazon, Berkshire Hathaway, and JPMorgan to create a healthcare company. They have indicated that is will be a...
Kiran Mazumdar-Shaw to deliver the prestigious IHC Annual Lecture

Kiran Mazumdar Shaw to Deliver the Prestigious IHC Annual Lecture on 5 February

Leading Entrepreneur Kiran Mazumdar-Shaw will deliver the IHC Annual Lecture on Monday, 5 February at 7pm at the Stein Auditorium, India Habitat Centre. She...
Biocon mylan

Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association’s...

Bengaluru, Karnataka, India and HERTFORDSHIRE, England, PITTSBURGH, June 10/11, 2017 – Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON)...
biocon academy website screenshot

Biocon Academy Introduces First Of Its Kind Career Advancement Program In ‘Clinical Development’ in...

Bengaluru, Karnataka, India, June 08, 2017: Biocon Academy, a CSR initiative of Asia’s leading biotechnology company, has announced the introduction of a unique program in...
Vaxon biotech

Vaxon announces results of its Phase IIb lung cancer trial of Vx-001

Paris, France, June 1, 2017 – Vaxon, a biopharmaceutical company developing therapeutic cancer vaccines based on optimized cryptic peptides, announces the results of its...
imcyse

Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes

Liège, Belgium, May 30, 2017 – Imcyse, who develop active specific therapies for the treatment and prevention of severe chronic diseases, today announces that...
medicen

Medicen Paris Region announces 20% business growth in 2016

Paris, May 18, 2017 – Medicen Paris Region, Europe’s leading healthcare cluster, today announces its review of business for the previous year. The 20%...